• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[Prevention of thromboembolic complications during cardioversion and catheter ablation in patients with atrial fibrillation: review of key randomized trials].

作者信息

Ionin V A

机构信息

Almazov National Medical Research Centre, Saint-Petersburg, Russia Pavlov University, Saint-Petersburg, Russia.

出版信息

Kardiologiia. 2020 Nov 12;60(10):99-106. doi: 10.18087/cardio.2020.10.n1289.

DOI:10.18087/cardio.2020.10.n1289
PMID:33228512
Abstract

This review focuses on the relevance of sinus rhythm control in patients with atrial fibrillation in real-life clinical practice and specific clinical features of patients with this arrhythmia. The authors presented current guidelines on prevention of thromboembolic complications and a review of results from major clinical studies of direct oral anticoagulants. The search for literature and selection of clinical studies for 2009-2020 were performed on websites of the European and Russian Societies of Cardiology, the All-Russian Scientific Society of Arrhythmologists, and in online databases PubMed, EMBASE, eLibrary, and Google Scholar using the key words atrial fibrillation, anticoagulants, ablation, cardioversion, and efficacy and safety.

摘要

相似文献

1
[Prevention of thromboembolic complications during cardioversion and catheter ablation in patients with atrial fibrillation: review of key randomized trials].
Kardiologiia. 2020 Nov 12;60(10):99-106. doi: 10.18087/cardio.2020.10.n1289.
2
Contemporary Management of Direct Oral Anticoagulants During Cardioversion and Ablation for Nonvalvular Atrial Fibrillation.非瓣膜性心房颤动转复和消融治疗期间直接口服抗凝剂的当代管理。
Pharmacotherapy. 2019 Jan;39(1):94-108. doi: 10.1002/phar.2205. Epub 2019 Jan 11.
3
Electrical cardioversion for atrial fibrillation and flutter.心房颤动和心房扑动的电复律
Cochrane Database Syst Rev. 2005 Jul 20(3):CD002903. doi: 10.1002/14651858.CD002903.pub2.
4
[Pericardioversion and catheter ablation use of rivaroxaban in light of X-VERT and VENTURE-AF trials].基于X-VERT和VENTURE-AF试验探讨利伐沙班在心包复律及导管消融中的应用
Turk Kardiyol Dern Ars. 2017 Sep;45(Suppl 4):15-23. doi: 10.5543/tkda.2017.27632.
5
Electrical cardioversion for atrial fibrillation and flutter.心房颤动和心房扑动的电复律
Cochrane Database Syst Rev. 2002(1):CD002903. doi: 10.1002/14651858.CD002903.
6
Meta-analysis of risk of stroke and thrombo-embolism with rivaroxaban versus vitamin K antagonists in ablation and cardioversion of atrial fibrillation.利伐沙班与维生素K拮抗剂用于房颤消融和复律时的卒中及血栓栓塞风险的荟萃分析。
Int J Cardiol. 2015;187:345-53. doi: 10.1016/j.ijcard.2015.03.323. Epub 2015 Mar 21.
7
Atrial fibrillation and stroke: elucidating a newly discovered risk factor.心房颤动与中风:阐明一个新发现的风险因素。
Am J Cardiol. 1997 Aug 28;80(4C):11D-18D; discussion 35D-39D. doi: 10.1016/s0002-9149(97)00580-8.
8
[Electrical cardioversion for non-valvular atrial fibrillation--underestimated risk for thromboembolic complications?].[非瓣膜性心房颤动的电复律——血栓栓塞并发症风险是否被低估?]
Dtsch Med Wochenschr. 2013 Jun;138(24):1309-11. doi: 10.1055/s-0033-1343211. Epub 2013 Jun 4.
9
Non-vitamin K antagonists oral anticoagulants are as safe and effective as warfarin for cardioversion of atrial fibrillation: A systematic review and meta-analysis.非维生素 K 拮抗剂口服抗凝药与华法林在心房颤动转复中同样安全有效:系统评价和荟萃分析。
Int J Cardiol. 2018 Oct 1;268:143-148. doi: 10.1016/j.ijcard.2018.04.034.
10
Cardioversion for atrial fibrillation - how to prevent thromboembolic complications?心房颤动的电复律 - 如何预防血栓栓塞并发症?
Ann Med. 2018 Nov;50(7):549-555. doi: 10.1080/07853890.2018.1523552. Epub 2018 Oct 15.